17-DMAG

CAS No.:467214-20-6

TBW04188
Alvespimycin;17-[2-(Dimethylamino)ethylamino]-17-desmethylgeldanamycin;17-Demethoxy-17-[[2-(dimethylamino)ethyl]amino]geldanamycin;17-DMAG;17DMAG;AlvespiMycin(17-DMAG);17-dimethylaminoethylamino-17-demethoxygeldanamycin;AlvespiMycin-d6;DMAG Hydrochloride;DMAG-d6;In-house Standard;KOS-1022;NSC 707545;DMAG;001L2FE0M3;NSC707545;AC-33174;KOS 1022;Q4552287;BDBM50005781;DB12442;17-DESMETHOXY-17-N,N-DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN;150270-08-9;M03709;BRD-K83988098-001-02-0;Alvespimycin [INN];GELDANAMYCIN, 17-DEMETHOXY-17-((2-(DIMETHYLAMINO)ETHYL)AMINO)-;alvespimycin;KOS1022;CS-0912;17-Dimethylaminogeldanamycin;HY-10389;EX-A1103;KUFRQPKVAWMTJO-LMZWQJSESA-N;17-(DIMETHYLAMINOETHYLAMINO)-17-DEMETHOXYGELDANAMYCIN HCL;UNII-001L2FE0M3;[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[2-(dimethylamino)ethylamino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate;17-dimethylaminoethylamino-17-demethoxy-geldanamycin;Dimethylaminoethylamino-17-demethoxygeldanamycin, 17-;BRD-K83988098-003-01-8;GTPL9828;((4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(2-dimethylaminoethylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo(16.3.1)docosa-4,6,10,18,21-pentaen-9-yl) carbamate;17-(dimethylaminoethylamino)-17-demethoxygeldanamycin;467214-20-6;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-((2-(DIMETHYLAMINO)ETHYL)AMINO)-13-HYDROXY-8,14-DIMETHOXY-4,10,12,16-TETRAMETHYL-3,20,22-TRIOXO-2-AZABICYCLO(16.3.1)DOCOSA-1(21),4,6,10,18-PENTAEN-9-YL CARBAMATE;17-(dimethylaminoethylamino)-17-demethoxy-geldanamycin;A1-50459;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-{[2-(dimethylamino)ethyl]amino}-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate;[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-21-[2-(dimethylamino)ethylamino]-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate;NSC-707545;CHEBI:65324;ALVESPIMYCIN [WHO-DD];DTXSID00963646;CHEBI:94772;(4E,6Z,10E,12S,13R,16R)-19-(2-(Dimethylamino)ethylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate;SCHEMBL5449716
inquiry
C32H48N4O8
616.75

Product introduction

Category: Drug Impurities and Intermediates
Appearance: powder
Purity: 95~98%(HPLC)
Storage conditions: -20°C under seal save, placed in ventilated, dry environment
Application: All our products are for research and lab only. Injecting, eating and other ways are forbidden.
Package: 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized
SMILES: O(C([H])([H])[H])[C@]1([H])[C@@]([H])([C@@]([H])(C([H])([H])[H])C([H])=C(C([H])([H])[H])[C@@]([H])([C@]([H])(C([H])=C([H])C([H])=C(C([H])([H])[H])C(N([H])C2=C([H])C(C(=C(C2=O)C([H])([H])[C@@]([H])(C([H])([H])[H])C1([H])[H])N([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])=O)=O)OC([H])([H])[H])OC(N([H])[H])=O)O[H] |c:16,31,t:27|